| Financial Year |
March 31 2023 |
| Monetary Funds |
249,096,261.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
55,324,100.96 |
| Accounts Receivable |
257,611,463.77 |
| Advances to Suppliers |
48,876,510.68 |
| Other Receivables |
27,315,828.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,928,269.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,372,479.09 |
| Total Current Assets |
791,222,135.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,804,700.00 |
| Long-term Equity Investment |
40,115,151.88 |
| Investment Properties |
-- |
| Fixed Assetes |
1,290,761,762.39 |
| Under-construction Projects |
592,404,239.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,656,642.54 |
| R&D expenses |
-- |
| Goodwill |
10,142,807.65 |
| Long-Term Deferred and Prepaid Expenses |
51,095,904.38 |
| Deferred Income Tax Assets |
10,291,567.60 |
| Other Non-Current Assets |
271,013,130.56 |
| Sub-Total of Non-Current Assets |
2,418,138,199.65 |
| Total Assets |
3,209,360,334.94 |
| Short-Term Loans |
466,942,082.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,751,784.86 |
| Accounts Payable |
93,596,852.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,133,151.19 |
| Taxes Payable |
19,042,946.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,529,555.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
167,969,619.87 |
| Other Current Liabilities |
61,902,169.42 |
| Sub-Total of Current Liabilities |
877,405,240.67 |
| Long-term Loans |
327,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
736,027,094.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,732,555.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,088,581,703.91 |
| Total Liabilities |
1,965,986,944.58 |
| Paid-In Capital(Or Share Stock) |
160,000,000.00 |
| Capital Surplus |
489,656,242.74 |
| Surplus Reserve |
36,349,032.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
544,691,370.76 |
| Minority Stockholder's Interest |
6,014,865.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,237,358,525.01 |
| Owner's Equity（Stockholder's Equity） |
1,243,373,390.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,209,360,334.94 |
